Fibromyalgia Syndrome: Etiology, Pathogenesis, Diagnosis, and Treatment

Overview

Journal Pain Res Treat

Date 2012 Dec 6

PMID 23213512

Citations 106

Authors

Enrico Bellato

Eleonora Marini

Filippo Castoldi

Nicola Barbasetti

Lorenzo Mattei

Davide Edoardo Bonasia

Davide Blonna

Affiliations

Soon will be listed here.

Abstract

Fibromyalgia syndrome is mainly characterized by pain, fatigue, and sleep disruption. The etiology of fibromyalgia is still unclear: if central sensitization is considered to be the main mechanism involved, then many other factors, genetic, immunological, and hormonal, may play an important role. The diagnosis is typically clinical (there are no laboratory abnormalities) and the physician must concentrate on pain and on its features. Additional symptoms (e.g., Raynaud's phenomenon, irritable bowel disease, and heat and cold intolerance) can be associated with this condition. A careful differential diagnosis is mandatory: fibromyalgia is not a diagnosis of exclusion. Since 1990, diagnosis has been principally based on the two major diagnostic criteria defined by the ACR. Recently, new criteria have been proposed. The main goals of the treatment are to alleviate pain, increase restorative sleep, and improve physical function. A multidisciplinary approach is optimal. While most nonsteroidal anti-inflammatory drugs and opioids have limited benefit, an important role is played by antidepressants and neuromodulating antiepileptics: currently duloxetine (NNT for a 30% pain reduction 7.2), milnacipran (NNT 19), and pregabalin (NNT 8.6) are the only drugs approved by the US Food and Drug Administration for the treatment of fibromyalgia. In addition, nonpharmacological treatments should be associated with drug therapy.

Citing Articles

How does chronic psychosocial distress induce pain? Focus on neuroinflammation and neuroplasticity changes.

Fulop B, Borbely E, Helyes Z Brain Behav Immun Health. 2025; 44:100964.

PMID: 40034488 PMC: 11875130. DOI: 10.1016/j.bbih.2025.100964.

Fibromyalgia, Depression, and Autoimmune Disorders: An Interconnected Web of Inflammation.

Sedda S, Cadoni M, Medici S, Aiello E, Erre G, Nivoli A Biomedicines. 2025; 13(2).

PMID: 40002916 PMC: 11853372. DOI: 10.3390/biomedicines13020503.

Differential Fatigue Profile in Patients with Post-COVID Condition, Fibromyalgia, and Multiple Sclerosis.

Oliver-Mas S, Matias-Guiu J, Delgado-Alonso C, Cuevas C, Alcala Ramirez Del Puerto J, Lopez-Carbonero J J Clin Med. 2025; 14(3).

PMID: 39941623 PMC: 11818582. DOI: 10.3390/jcm14030952.

Biochemical analysis of miR-217 and miR-532 in patients with fibromyalgia.

Ayoub S, Ahmed A, Abdelwahed M, Khalefa A, Awaji A, Zekry S Eur J Med Res. 2025; 30(1):85.

PMID: 39920875 PMC: 11803959. DOI: 10.1186/s40001-025-02330-y.

Proinflammatory diet is associated with higher pain, disease severity and biochemical parameters associated with inflammation in fibromyalgia.

Ersoy Soke N, Inceoz H, Solmaz I, Yardimci H Pain Med. 2024; 26(3):131-139.

PMID: 39565919 PMC: 11879218. DOI: 10.1093/pm/pnae118.

References

Wolfe F, Smythe H, Yunus M, Bennett R, Bombardier C, Goldenberg D . The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum. 1990; 33(2):160-72. DOI: 10.1002/art.1780330203. View

Fayed N, Garcia-Campayo J, Magallon R, Andres-Bergareche H, Luciano J, Andres E . Localized 1H-NMR spectroscopy in patients with fibromyalgia: a controlled study of changes in cerebral glutamate/glutamine, inositol, choline, and N-acetylaspartate. Arthritis Res Ther. 2010; 12(4):R134. PMC: 2945024. DOI: 10.1186/ar3072. View

Wolfe F . New American College of Rheumatology criteria for fibromyalgia: a twenty-year journey. Arthritis Care Res (Hoboken). 2010; 62(5):583-4. DOI: 10.1002/acr.20156. View

Jensen K, Kosek E, Petzke F, Carville S, Fransson P, Marcus H . Evidence of dysfunctional pain inhibition in Fibromyalgia reflected in rACC during provoked pain. Pain. 2009; 144(1-2):95-100. DOI: 10.1016/j.pain.2009.03.018. View

Wolfe F, Russell I, Vipraio G, Ross K, Anderson J . Serotonin levels, pain threshold, and fibromyalgia symptoms in the general population. J Rheumatol. 1997; 24(3):555-9. View

Andre-Obadia N, Peyron R, Mertens P, Mauguiere F, Laurent B, Garcia-Larrea L . Transcranial magnetic stimulation for pain control. Double-blind study of different frequencies against placebo, and correlation with motor cortex stimulation efficacy. Clin Neurophysiol. 2006; 117(7):1536-44. DOI: 10.1016/j.clinph.2006.03.025. View

Crofford L, Mease P, Simpson S, Young Jr J, Martin S, Haig G . Fibromyalgia relapse evaluation and efficacy for durability of meaningful relief (FREEDOM): a 6-month, double-blind, placebo-controlled trial with pregabalin. Pain. 2008; 136(3):419-431. DOI: 10.1016/j.pain.2008.02.027. View

Cohen H, Neumann L, Haiman Y, Matar M, Press J, Buskila D . Prevalence of post-traumatic stress disorder in fibromyalgia patients: overlapping syndromes or post-traumatic fibromyalgia syndrome?. Semin Arthritis Rheum. 2002; 32(1):38-50. DOI: 10.1053/sarh.2002.33719. View

McBeth J, Silman A . The role of psychiatric disorders in fibromyalgia. Curr Rheumatol Rep. 2001; 3(2):157-64. DOI: 10.1007/s11926-001-0011-8. View

10.

Sundgren P, Petrou M, Harris R, Fan X, Foerster B, Mehrotra N . Diffusion-weighted and diffusion tensor imaging in fibromyalgia patients: a prospective study of whole brain diffusivity, apparent diffusion coefficient, and fraction anisotropy in different regions of the brain and correlation with symptom severity. Acad Radiol. 2007; 14(7):839-46. DOI: 10.1016/j.acra.2007.03.015. View

11.

Buskila D, Sarzi-Puttini P, Ablin J . The genetics of fibromyalgia syndrome. Pharmacogenomics. 2006; 8(1):67-74. DOI: 10.2217/14622416.8.1.67. View

12.

Rock R, Gekker G, Hu S, Sheng W, Cheeran M, Lokensgard J . Role of microglia in central nervous system infections. Clin Microbiol Rev. 2004; 17(4):942-64, table of contents. PMC: 523558. DOI: 10.1128/CMR.17.4.942-964.2004. View

13.

Greenfield S, Fitzcharles M, Esdaile J . Reactive fibromyalgia syndrome. Arthritis Rheum. 1992; 35(6):678-81. DOI: 10.1002/art.1780350612. View

14.

Houvenagel E, Forzy G, Leloire O, Gallois P, Hary S, Hautecoeur P . [Cerebrospinal fluid monoamines in primary fibromyalgia]. Rev Rhum Mal Osteoartic. 1990; 57(1):21-3. View

15.

Chang Y, Kim J, Song H, Seo J, Kim S, Han S . Insular cortex is a trait marker for pain processing in fibromyalgia syndrome--blood oxygenation level-dependent functional magnetic resonance imaging study in Korea. Clin Exp Rheumatol. 2011; 29(6 Suppl 69):S19-27. View

16.

Gursoy S, Erdal E, Herken H, Madenci E, Alasehirli B, Erdal N . Significance of catechol-O-methyltransferase gene polymorphism in fibromyalgia syndrome. Rheumatol Int. 2003; 23(3):104-7. DOI: 10.1007/s00296-002-0260-5. View

17.

Mease P, Arnold L, Choy E, Clauw D, Crofford L, Glass J . Fibromyalgia syndrome module at OMERACT 9: domain construct. J Rheumatol. 2009; 36(10):2318-29. PMC: 3419373. DOI: 10.3899/jrheum.090367. View

18.

Wang C, Schmid C, Rones R, Kalish R, Yinh J, Goldenberg D . A randomized trial of tai chi for fibromyalgia. N Engl J Med. 2010; 363(8):743-54. PMC: 3023168. DOI: 10.1056/NEJMoa0912611. View

19.

WAYLONIS G, Perkins R . Post-traumatic fibromyalgia. A long-term follow-up. Am J Phys Med Rehabil. 1994; 73(6):403-12. DOI: 10.1097/00002060-199411000-00005. View

20.

Fregni F, Freedman S, Pascual-Leone A . Recent advances in the treatment of chronic pain with non-invasive brain stimulation techniques. Lancet Neurol. 2007; 6(2):188-91. DOI: 10.1016/S1474-4422(07)70032-7. View